We studied 20 healthy volunteers who were tested on two occasions receiving either ebselen (3600mg over 24 hours) or identical placebo in a double-blind, random-order, cross-over design. Two hours after the final dose of ebselen/placebo, participants underwent proton magnetic resonance spectroscopy ( 1 H MRS) at 7 tesla (7T) with voxels placed in anterior cingulate and occipital cortex (Figure 1 ). Neurometabolite levels were calculated using an unsuppressed water signal as a reference and corrected for individual cerebrospinal fluid content in the voxel. Results: Ebselen produced no effect on neurometabolite levels in the occipital cortex. In the anterior cingulate cortex, ebselen lowered concentrations of inositol as well as those of glutathione, glutamine, glutamate and Glx (Table 1) .
change in medication ameliorated both the tremors and the depressive symptoms. She was discharged from the hospital after 2 months. However, her parkinsonism worsened 4 months after discharge. The subsequent exacerbation of parkinsonism left her bedridden and unable to walk by herself. Her Unified Parkinson's Disease Rating Scale score was 98. Because druginduced parkinsonism was suspected, VPA was gradually withdrawn thereafter. Forty-five days later, she was able to walk by herself with a cane. The Unified Parkinson's Disease Rating Scale score improved to 11. Improvement of parkinsonism after withdrawal of the medication led us to diagnose her as age-related vascular parkinsonism exacerbated by medication. Previous studies showed that approximately 20% of patients on chronic VPA therapy developed tremor (Aleksandar J et al., 2006) . In majority of the previously reported VPA-induced parkinsonism cases, the parkinsonism was improved after discontinuation of the drug (Mahmoud F et al., 2011) . Although drug-induced parkinsonism is a frequent side-effect of VPA, severe cases such as the present case are uncommon. The recognition of VPA-induced parkinsonism is of great clinical significance, because appropriate treatment results in significant improvement of symptoms.
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A smaller percentage of unipolar depression patients with manic or hypomanic switch during acute antidepressant treatment convert to bipolar disorder 
Hiroshima Citizens Hospital, Japan
Abstract Objective: To investigate 3-year outcomes of unipolar depression patients with manic or hypomanic switch during acute antidepressant treatment. Methods: A review of medical records revealed 37 consecutive patients admitted from 1997 to 2002 who underwent an antidepressant-induced manic or hypomanic switch fulfilling DSM-IV criteria. Their clinical courses were retrospectively investigated after discharge. Results: Of the 37 patients, 29 (78.4%) were followed for 3 year after discharge. None developed a manic episode, while 10 developed a hypomanic episode, including 2 patient who were lost after emerging from a hypomanic episode during the observation period. Only 2 of those 10 patients developed hypomania during acute antidepressant treatment for a recurrent depressive episode under maintenance mood stabilizer treatment. Furthermore, bipolar conversion occurred in 6 patients within the first 1 year, including 1 with rapid cycling, and in another 2 patients over the subsequent 1 year after discharge. Of these 29 patients, 23 (79.3%) received continuous maintenance treatment with mood stabilizers for the 3-year period after discharge. Conclusions: A smaller percentage of unipolar depression patients with manic or hypomanic switch during acute antidepressant treatment converted to bipolar disorder. Bipolar conversion subsequently decreased and did not occur from 2 to 3 years after discharge. Longer follow-up studies appear warranted determine the diagnostic issues of antidepressantinduced switch in unipolar depression.
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P600 alteration of syntactic language processing in patients with bipolar mania:comparison to schizophrenic patients and healthy subjects Seoul National Hospital, Republic of Korea Abstract Background: Disturbances in thought, speech, and linguistic processing are frequently observed in bipolar manic patients, but the underlying neurophysiological mechanisms are not well understood. P600 is a distinct, positive event-related potential component elicited by syntactic violations. Using the P600 ERP, we examined neural processing of syntactic language comprehension in patients with bipolar mania compared to patients with schizophrenia and healthy people. Method: P600s were recorded from 21 manic patients with bipolar disorder, 26 patients with schizophrenia, and 29 healthy subjects during the presentation of 120 sentences with syntactic violations or non-violations. Subjects were asked to judge whether each sentence was correct or incorrect. Results: Patients with mania and schizophrenia had significantly smaller P600 amplitudes associated with syntactic violations compared with healthy subjects. There was no difference in P600 amplitude between patient groups. For behavioral performance, patients with schizophrenia were significantly less accurate compared with healthy subjects, whereas manic patients were not significantly different from healthy subjects. Conclusion: Despite having normal behavioral judgment of syntax, patients with bipolar mania have reduced P600 amplitude, comparable to patients with schizophrenia. Our findings may represent the first neurophysiological evidence of abnormal syntactic linguistic processing in bipolar mania.
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Time perception with auditory stimulus and manic symptoms in bipolar patients MD 1 
